Muna I Naash Selected Research

Retinal Diseases

10/2021	Modulation of SOD3 Levels Is Detrimental to Retinal Homeostasis.
1/2021	Photoreceptor Disc Enclosure Is Tightly Controlled by Peripherin-2 Oligomerization.
1/2021	Gene Therapy to the Retina and the Cochlea.
10/2020	Retbindin: A riboflavin Binding Protein, Is Critical for Photoreceptor Homeostasis and Survival in Models of Retinal Degeneration.
1/2020	The Interplay between Peripherin 2 Complex Formation and Degenerative Retinal Diseases.
1/2020	Pluripotent Stem Cells for the Treatment of Retinal Degeneration: Current Strategies and Future Directions.
1/2019	Prph2 initiates outer segment morphogenesis but maturation requires Prph2/Rom1 oligomerization.
1/2018	DNA nanoparticles are safe and nontoxic in non-human primate eyes.
3/2016	Role of RDS and Rhodopsin in Cngb1-Related Retinal Degeneration.
1/2016	Characterization of Ribozymes Targeting a Congenital Night Blindness Mutation in Rhodopsin Mutation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muna I Naash Research Topics

Disease

42	Retinal Degeneration 01/2021 - 10/2003
19	Retinal Diseases 10/2021 - 01/2003
16	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2021 - 01/2007
9	Macular Degeneration (Age-Related Maculopathy) 10/2021 - 09/2004
6	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2021 - 01/2013
5	Cone-Rod Dystrophies 10/2020 - 09/2004
4	Retinal Detachment (Retinal Detachments) 05/2014 - 10/2003
3	congenital stationary Night blindness 01/2016 - 10/2004
3	Blindness (Hysterical Blindness) 10/2014 - 09/2010
2	Riboflavin Deficiency 01/2022 - 01/2019
2	Hyperglycemia 01/2019 - 01/2013
2	Stargardt Disease 01/2016 - 09/2012
1	Inflammation (Inflammations) 09/2021
1	Cochlear Diseases 01/2021
1	Phototoxic Dermatitis (Phototoxicity) 01/2020
1	Hypoxia (Hypoxemia) 01/2016
1	Night Blindness (Nyctalopia) 01/2016
1	Retinal Dystrophies 02/2015
1	Wounds and Injuries (Trauma) 05/2014
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 05/2014
1	Cataract (Cataracts) 05/2014
1	Vitelliform Macular Dystrophy 04/2013
1	Microaneurysm 01/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013
1	Enhanced S-Cone Syndrome 01/2013
1	Edema (Dropsy) 02/2008
1	Ganglion Cysts (Ganglion) 01/2007
1	Retinal Neoplasms 03/2004

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2004
16	PeripherinsIBA 01/2021 - 08/2004
14	Retinaldehyde (Retinal)IBA 01/2022 - 10/2003
11	TetraspaninsIBA 01/2020 - 01/2008
7	Rhodopsin (Visual Purple)IBA 10/2020 - 01/2003
7	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2009
4	Glycoproteins (Glycoprotein)IBA 01/2016 - 01/2008
3	riboflavin-binding proteinIBA 01/2021 - 01/2020
3	FlavinsIBA 01/2021 - 01/2019
3	Codon (Codons)IBA 01/2018 - 02/2010
2	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022 - 10/2020
2	Flavin-Adenine Dinucleotide (FAD)IBA 10/2020 - 12/2018
2	Flavin Mononucleotide (FMN)IBA 10/2020 - 12/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2016
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018 - 04/2012
2	AntioxidantsIBA 01/2016 - 10/2014
2	Tyrosine (L-Tyrosine)FDA Link 05/2014 - 02/2014
2	fibulin 2IBA 05/2014 - 02/2014
2	DisulfidesIBA 12/2010 - 03/2009
2	OpsinsIBA 04/2010 - 10/2004
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2010 - 03/2009
2	denufosol tetrasodiumIBA 02/2008 - 10/2003
1	tyrosine O-sulfateIBA 09/2021
1	Serine (L-Serine)FDA Link 10/2020
1	Superoxide DismutaseIBA 01/2019
1	4,6-dinitro-o-cresol (DNOC)IBA 01/2019
1	PolylysineIBA 01/2018
1	Histidine (L-Histidine)FDA Link 01/2018
1	LipidsIBA 01/2018
1	Proline (L-Proline)FDA Link 01/2018
1	Cyclic Nucleotide-Gated Cation ChannelsIBA 03/2016
1	Catalytic RNA (Ribozymes)IBA 01/2016
1	Free RadicalsIBA 01/2016
1	PolymersIBA 09/2015
1	Peptides (Polypeptides)IBA 09/2015
1	Liposomes (Liposome)IBA 09/2015
1	guanylate cyclase 1IBA 02/2015
1	SNARE Proteins (SNAREs)IBA 01/2015
1	yttria (yttrium oxide)IBA 10/2014
1	Retinal Pigments (Pigments, Visual)IBA 06/2014
1	Mutant Proteins (Protein, Mutant)IBA 12/2013
1	Biological ProductsIBA 01/2013
1	Lysine (L-Lysine)FDA Link 04/2012
1	Cysteine (L-Cysteine)FDA Link 12/2010
1	Pharmaceutical PreparationsIBA 02/2008
1	Glial Fibrillary Acidic ProteinIBA 01/2007
1	TubulinIBA 01/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2007
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 06/2005
1	Arginine (L-Arginine)FDA Link 09/2004
1	Tryptophan (L-Tryptophan)FDA Link 09/2004
1	interstitial retinol-binding proteinIBA 03/2004
1	AntigensIBA 03/2004
1	Tumor Viral Antigens (Large T Antigen)IBA 03/2004
1	Saline SolutionIBA 10/2003

Therapy/Procedure

10	Therapeutics 01/2021 - 10/2003
1	Intravitreal Injections 09/2021
1	Microspheres (Microsphere) 10/2003
1	Injections 10/2003